The 20 Best Mediastinal Tumor Doctors Near Me in Annapolis, MD

Wyndham Wilson is an Oncologist practicing medicine in Bethesda, Maryland. Dr. Wilson is rated as a Distinguished provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

Russell Hales, M.D., is an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also is director of the thoracic multidisciplinary clinic. His research focuses on reconstructing health delivery models to enhance value and improve clinical outcomes. He also studies the effect of immunotherapy and RT in thoracic tumors. Dr. Hales was awarded an R21 grant to study the use of dynamic MRI in predicting tumor motion in patient with lung cancer. Taken together, his research focuses on optimizing patient outcomes using resources from physics, engineering, biology and health delivery systems. Dr. Hales’ efforts extend beyond radiation oncology and clinical management. He has helped to lead in the thoracic oncology program, which includes 20 faculty members and nearly 50 staff, to help chart a vision for this program’s future. In the last four years, the program has gradually transitioned from The Johns Hopkins Hospital campus to Johns Hopkins Bayview Medical Center. Dr. Hales was tasked to head the building and design committee that worked with architects to create a structure conducive to 21st century oncology care. His work extends beyond the bricks and mortar of the new cancer center today to team development within the thoracic oncology program. Simply put, the thoracic oncology move was designed to conceptualize the transition of care from department-based to disease-based medicine. As such, Dr. Hales has worked to integrate the efforts of specialists in medical oncology, thoracic surgery, interventional pulmonology, pathology and radiology. These experts share a clinical space focused on thoracic malignancies and bring a patient-centered model of care to their group. Dr. Hales graduated from Brigham Young University Summa Cum Laude and Valedictorian in 2001. He attended Johns Hopkins Medicine and graduated with an M.D. in 2005. He trained on the Osler Medical Service and attended residency at Johns Hopkins. He joined the faculty at Hopkins in 2010. Dr. Hales focus in program building, research and clinical endeavors is robust, but he understands the key role of academia in training future leaders in medicine. He has been awarded Teacher of the Year in the department of radiation oncology at Hopkins for three of the last six years. He is a well-respected lecturer and travels nationally to speak at conferences and educational workshops about novel therapies in lung and esophagus cancer. Make A Gift. Dr. Hales is rated as an Advanced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Thymic Epithelial Tumor, and Non-Small Cell Lung Cancer (NSCLC). Dr. Hales is board certified in American Board Of Radiology.

Dr. K. Ranh Voong specializes in thoracic malignancies, including lung, esophageal, thymic cancers, and mesothelioma. She treats patients at both the Johns Hopkins Thoracic Center of Excellence at Johns Hopkins Bayview and at the Proton Center at Sibley Memorial Hospital. She has extensive expertise in proton therapy, SBRT, IMRT for tumors involving the chest. She is the Principal Investigator on grants from Lung Cancer Research Foundation and Hopkins-Wellspan. She is the Principal Investigator of a prospective study evaluating the immunogenic effects of SABR alone on systemic T cell response in patients with stage I NSCLC. She is the principal investigator of a multi-institutional prospective trial showing that routine review of patient-reported outcome measures informs radiation on-treatment toxicity burden assessment and care delivery. She was the Quality of Life Co-chair of a Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (NRG-LU006). She has been invited to participate in national and regularly lectures on thoracic malignancies and protons for thoracic malignancies therapy. In her research, Dr. Voong is dedicated to improving the outcomes of patients with thoracic malignancies, by exploring avenues to better understand and optimize the delivery of radiotherapy. Dr. Voong is also the Program Director for the Radiation Oncology Residency Program. She mentors residents, medical students. Make A Gift. Dr. Voong is rated as an Advanced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Voong is board certified in American Board Of Radiology.

Peter Cheng is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Mediastinal Tumor. Dr. Cheng is board certified in American Board Of Internal Medicine.

John Pappas, MD specializes in Diagnostic Radiology, Interventional Radiology and Vascular Interventional Radiology and practices with Allegheny Imaging, PC and is affiliated with UPMC Somerset.  Dr. Pappas completed his medical education at Einstein College of Medicine and is board certified in Interventional Radiology and Diagnostic Radiology by the American Board of Radiology. Dr. Pappas is rated as an Advanced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Stroke, Ascites, Thyroid Nodule, Liver Embolization, and Bone Marrow Aspiration. Dr. Pappas is board certified in American Board Of Radiology and American Board Of Radiology.

Richard Battafarano, M.D., Ph.D., joins the Johns Hopkins Department of Surgery as director of the Division of General Thoracic Surgery and the first regional director of general thoracic surgery. He comes to Johns Hopkins from University of Maryland Medical System, where he was chief of the Division of Thoracic Surgery. Dr. Battafarano specializes in the treatment of benign and malignant diseases and lesions of the chest, including minimally invasive operations such as video-assisted thoracscopic surgery (VATS) for lung and esophageal cancers. He also has a special interest in treating Barretts esophagus, emphysema, mesothelioma and paraesophageal hernias. The focus of Dr. Battafaranos basic and translational research includes outcomes in the surgical management of early stage lung cancer patients with neuroendocrine histology, optimal management of lung cancer patients with mediastinal lymph node metastases, and the effect of survivin overexpression in the development of esophageal cancer. Dr. Battafarano sees patients at The Johns Hopkins Hospital and the Johns Hopkins Health Care & Surgery Centers at Green Spring Station and at White Marsh. Dr. Battafarano is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Thymic Epithelial Tumor, Pleuropulmonary Blastoma, Gastrectomy, and Endoscopy. Dr. Battafarano is board certified in American Board Of Thoracic Surgery.

Ahmet Kilic is a cardiac surgeon in Baltimore, Maryland. He is an associate professor of surgery at the Baltimore-based Johns Hopkins University School of Medicine. He also serves as director of heart transplantation and mechanical circulatory support. Dr. Kilic's areas of clinical expertise include adult cardiac surgery with a special interest in heart transplantation and mechanical circulatory support. Prior to joining Johns Hopkins, Dr. Kilic served as associate professor of surgery at The Ohio State University Wexner Medical Center and was the director of the heart transplant and mechanical circulatory support programs. He was co-director of the advanced heart failure program as well as the vice director of clinical and academic affairs in the division of cardiac surgery. Although a recognized leader in the field of heart failure, Dr. Kilic’s expertise runs the spectrum of cardiac surgery. Dr. Kilic is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Heart Tumor, Restrictive Cardiomyopathy (RCM), Supravalvular Aortic Stenosis, Heart Transplant, and Heart Bypass Surgery. Dr. Kilic is board certified in American Board Of Thoracic Surgery.

Mark Nelson, MD, specializes in cardiothoracic surgery and is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. He practices at UPMC Heart and Vascular Institute and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Nelson completed his fellowship and residency at West Virginia University School of Medicine and medical education at University of Maryland School of Medicine. Dr. Nelson is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Carotid Artery Disease, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Heart Bypass Surgery. Dr. Nelson is board certified in American Board Of Surgery and American Board Of Thoracic Surgery.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Linda Chi Hang Chu is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her clinical expertise includes body CT, MRI and US. Her research interests include abdominal imaging, cancer imaging, radiomics, and artificial intelligence. Dr. Chu graduated from the University of Toronto in 2003 and was awarded the Governor General's Silver Medal, the highest academic achievement from the undergraduate program. She earned her medical degree as a member of AOA and phi beta kappa from Johns Hopkins University in Baltimore, MD in 2007. She completed her Diagnostic Radiology residency and body MRI fellowship at Johns Hopkins Hospital. Dr. Chu joined the Johns Hopkins faculty in 2013. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Chu is board certified in American Board Of Radiology.

As an Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences, I specialize in palliative radiation oncology with a focus on improving access to high-quality, compassionate care for patients with advanced cancer. I am the founder and director of the Palliative Radiation and Supportive Medicine (PRISM) Service, a program dedicated to enhancing the role of radiation therapy in symptom management and end-of-life care. In addition, I am part of our breast radiation oncology team, and I guide clinical care and treatment strategies for patients with breast cancer at the Johns Hopkins Hospital. My clinical efforts center on expanding access to palliative radiation through infrastructural development, interdisciplinary collaboration, and innovative treatment approaches. I am deeply committed to advancing health equity and addressing disparities in cancer care delivery. My work also seeks to bridge the gap between radiation oncology and the health humanities, fostering a more holistic, human-centered approach to clinical practice that supports the emotional, social, and cultural dimensions of patient care. Dr. Lavigne is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Mediastinal Tumor, and Bone Tumor.

Dr. Cheng Ting Lin is an associate professor of radiology and radiological science at the Johns Hopkins University School of Medicine. His expertise is in diagnostic radiology with particular focus on chest and cardiac imaging. Dr. Cheng Ting Lin received his undergraduate degree from Boston University. He graduated from State University of New York at Stony Brook, where he also completed a radiology residency training program. Dr. Lin completed fellowship training in cardiothoracic imaging at University of Maryland Medical Center. His research interest includes lung cancer screening and diagnosis, chronic obstructive pulmonary disease, Interstitial lung disease, pulmonary embolism, and coronary artery disease. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Interstitial Lung Disease, Pulmonary Arteriovenous Fistula, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Lin is board certified in American Board Of Radiology.

Dr. Julianna Czum’s primary focus is cardiothoracic imaging, with clinical subspecialties in noninvasive cardiovascular and thoracic imaging. Dr. Czum earned her medical degree from UMDNJ - Robert Wood Johnson Medical School before going on to an internship at Mary Imogene Bassett Hospital and residency at St. Barnabas Medical Center. She completed a fellowship in cardiovascular magnetic resonance in a combined Henry Jackson Foundation-funded program at the National Institutes of Health, National Naval Medical Center and Uniformed Services University of the Health Sciences. Dr. Czum joined the diagnostic faculty in June 2022. Dr. Czum is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Chronic Cough, and Lung Nodules. Dr. Czum is board certified in American Board Of Radiology.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

Peter Libby is a Neuroradiologist practicing medicine in Salisbury, Maryland. Dr. Libby is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Stroke, Bronchogenic Cyst, Gallbladder Disease, Vertebroplasty, and Bone Graft.

Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pulmonary Fibrosis, Collapsed Lung, Lung Transplant, and Heart Transplant. Dr. Bush is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Sastry is board certified in American Board Of Internal Medicine.